ClinicalTrials.gg
Not yet recruitingNCT07363096ESP-LumbarUpdated Jan 23, 2026

Single- Versus Two-Level ESP Block for Analgesia After Lumbar Stabilization Surgery

An interventional study of Single-Level Erector Spinae Plane Block and Two-Level Erector Spinae Plane Block in Postoperative Pain Management, Lumbar Spinal Fusion Surgery and Erector Spina Plan Block, sponsored by Ankara Etlik City Hospital. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-01-23.

Sponsored by Ankara Etlik City Hospital · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 158 studies in Acute Pain with a site in Turkey — 23 open to participants now, 26 under way, none of them phase 3. Acute Pain · Turkey.

Planned enrollment
93rd of 135
60 · median 80
Started
2026
with 14 others
No phase
130 of 158
19 open now
Primary completion
2027-01
later than 20 of 25 live
Registered
142nd of 158
by date
Lead sponsor
9 of 158
Ankara Etlik City Hospital

Among the 158 studies in Acute Pain with a site in Turkey, this one is the 93rd largest by planned enrollment of the 135 interventional ones that give a count, is one of 15 that started in 2026, is one of 130 with no phase, reaches primary completion later than 20 of the 25 other live ones, and was the 142nd registered.

Acute Pain

1,077 studies on the registry are indexed under Acute Pain; 168 are open to participants now.

Browse Acute Pain studies →

Open to participants now

23 of the 158 studies in Acute Pain with a site in Turkey are open now. Recruiting first, the newest first:

18 more — sign in →

All 23 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 103 Acute Pain studies recruiting now, 40 (39%) set no upper age limit and 50 (49%) stop at 75 or younger; 21 take children under 18; 24 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 158 studies in Acute Pain with a site in Turkey, or all of them as a file.
02

Study summary

Lumbar stabilization surgery is commonly associated with moderate to severe postoperative pain. Effective pain control is important to improve patient comfort, early mobilization, and recovery. The erector spinae plane (ESP) block is a regional anesthesia technique that has been increasingly used for postoperative pain management in spine surgery.

This study aims to compare the effectiveness of single-level versus two-level ultrasound-guided ESP block for postoperative pain control in patients undergoing lumbar stabilization surgery. Patients will be randomly assigned to receive either a single-level ESP block or a two-level ESP block in addition to standard analgesic treatment.

Postoperative pain scores, opioid consumption, and the incidence of side effects will be evaluated during the postoperative period. The results of this study may help determine the most effective ESP block technique for pain management after lumbar stabilization surgery.

03

Conditions studied

  • Postoperative Pain Management
  • Lumbar Spinal Fusion Surgery
  • Erector Spina Plan Block

Browse trials for

Keywords

  • Erector Spina Plane Block
  • Acute Pain
  • Postoperative Pain Management
04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • -III,
  • :18-40,
  • Patients undergoing lumbar stabilization surgery involving 2 to 4 vertebral levels
  • Patients who personally provide written to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Patients with chronic pain conditions
  • Patients with a history of chronic opioid use
  • Patients undergoing emergency lumbar stabilization surgery
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Care provider, Investigator, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    Single Level Erector Spinae Plane Block

    Participants in this arm will receive an ultrasound-guided erector spinae plane (ESP) block performed at a single vertebral level corresponding to the surgical site, in addition to standardized general anesthesia and postoperative multimodal analgesia.

    Procedure: Single-Level Erector Spinae Plane Block

  • Active comparator
    Two Level Erector Spinae Plane Block

    Participants in this arm will receive an ultrasound-guided erector spinae plane (ESP) block performed at two adjacent vertebral levels, in addition to standardized general anesthesia and postoperative multimodal analgesia.

    Procedure: Two-Level Erector Spinae Plane Block

Interventions

  • ProcedureSingle-Level Erector Spinae Plane Block

    Ultrasound-guided erector spinae plane block performed at a single vertebral level for postoperative analgesia.

  • ProcedureTwo-Level Erector Spinae Plane Block

    Ultrasound-guided erector spinae plane block performed at two adjacent vertebral levels for postoperative analgesia.

06

What researchers measure

Primary outcomes

  1. Intraoperative Remifentanyl Consumption

    The amount of Remifentanyl that patients need to maintain anesthesia during the intraoperative period will be recorded

    Time frame: During the intraoperative period

Secondary outcomes

  1. Pain Scores

    Pain will be assessed at rest and while movement using the from 0 ( no pain) to 10 (worst pain). Pain assessment will be done at the 1st, 2nd, 4th, 12th and 24th hours after surgery

    Time frame: First 24 hours after surgery

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Feb 2026; primary completion for Jan 2027, 11 months later.

Of 425 non-industry interventional studies with no phase under Acute Pain, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 23. This study's planned 11 months is close to that.

Counting every sponsor, half of 431 studies reached it within 11 months; a quarter within 5 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 15, 2026
First posted
Jan 23, 2026
StartEst.
Feb 1, 2026
Primary completionEst.
Jan 1, 2027
CompletionEst.
Jan 3, 2027
Last update
Jan 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07363096
Responsible party
Hatice Ayça Sarıbudak (Anesthesiology and Reanimation Specialist, Ankara Etlik City Hospital) — Principal investigator
First posted
Jan 23, 2026
Start date
Feb 1, 2026 (estimated)
Primary completion
Jan 1, 2027 (estimated)
Completion
Jan 3, 2027 (estimated)
Last update
Jan 23, 2026

Study contacts

Hatice Ayça SARIBUDAK, MD
Contact
aycasaribudak@gmail.com
905437290893

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion